MCO vs NEUP · P/E 33, rev $4.26B vs rev $15.7M
Moodys Corporation (MCO) versus Neuphoria Therapeutics Inc (NEUP) — a side-by-side from cached financials, not a winner call.
Moodys Corporation (MCO) is a financial data & stock exchanges company listed on NYSE.
Neuphoria Therapeutics Inc (NEUP) is a biotechnology company listed on NASDAQ.
Latest reported MCO revenue for 2026-06-30 was $4.26B. Net income was $1.54B. MCO currently screens at market cap $79.69B and trailing P/E 32.7.
Latest reported NEUP revenue for 2025-03-31 was $15.7M. Net income was $8.5M. NEUP currently screens at market cap $23.6M.
MCO currently screens at market cap $79.69B and trailing P/E 32.7. NEUP currently screens at market cap $23.6M.
Not investment advice. Open the MCO and NEUP stock pages for the full models.
Not investment advice.